Your information is allways very usefull.
FDA Approves New COPD Treatment — Physician’s First Watch
FDA Approves New COPD Treatment
By the Editors
The FDA has approved olodaterol (Striverdi Respimat) inhalation spray as a once-daily maintenance therapy for chronic obstructive pulmonary disease.
In a trial of 3100 people with COPD, those who took the medication had improved lung function, compared with those who took placebo. Like other long-acting beta-adrenergic agonists, olodaterol will include a boxed warning highlighting the increase risk for asthma-related death.